Stenocare A/S (CPH:STENO)
1.085
+0.020 (1.88%)
Apr 28, 2026, 4:48 PM CET
Stenocare Income Statement
Financials in millions DKK. Fiscal year is January - December.
Millions DKK. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2018 |
| Revenue | 7.02 | 2.23 | 3.76 | 4.49 | 1.89 | Upgrade
|
| Revenue Growth (YoY) | 214.56% | -40.61% | -16.30% | 137.54% | 852.38% | Upgrade
|
| Cost of Revenue | 5.8 | 7.66 | 9.94 | 10.9 | 7.9 | Upgrade
|
| Gross Profit | 1.22 | -5.42 | -6.19 | -6.41 | -6.01 | Upgrade
|
| Selling, General & Admin | 2.93 | 5.76 | 6.38 | 6.81 | 7.23 | Upgrade
|
| Operating Expenses | 3 | 9.48 | 9.76 | 10.12 | 8.07 | Upgrade
|
| Operating Income | -1.77 | -14.9 | -15.95 | -16.53 | -14.08 | Upgrade
|
| Interest Expense | -0.66 | -1.54 | -2.88 | -1.29 | -0.21 | Upgrade
|
| Interest & Investment Income | 0.01 | 0.03 | - | 0.02 | 0.03 | Upgrade
|
| Earnings From Equity Investments | 0.03 | -0 | - | -0.08 | - | Upgrade
|
| EBT Excluding Unusual Items | -2.39 | -16.41 | -18.82 | -17.89 | -14.26 | Upgrade
|
| Merger & Restructuring Charges | - | -13.05 | - | - | - | Upgrade
|
| Asset Writedown | - | -5.14 | - | - | - | Upgrade
|
| Pretax Income | -2.39 | -34.6 | -18.82 | -17.89 | -14.26 | Upgrade
|
| Income Tax Expense | - | -0.11 | -1.25 | -1.58 | -1.53 | Upgrade
|
| Net Income | -2.39 | -34.49 | -17.57 | -16.3 | -12.73 | Upgrade
|
| Net Income to Common | -2.39 | -34.49 | -17.57 | -16.3 | -12.73 | Upgrade
|
| Shares Outstanding (Basic) | 40 | 19 | 14 | 11 | 12 | Upgrade
|
| Shares Outstanding (Diluted) | 40 | 19 | 14 | 11 | 12 | Upgrade
|
| Shares Change (YoY) | 106.79% | 38.17% | 22.09% | -2.22% | 11.00% | Upgrade
|
| EPS (Basic) | -0.06 | -1.79 | -1.26 | -1.43 | -1.09 | Upgrade
|
| EPS (Diluted) | -0.06 | -1.79 | -1.26 | -1.43 | -1.09 | Upgrade
|
| Free Cash Flow | -7.2 | -7.19 | -10.22 | -15.97 | -16.61 | Upgrade
|
| Free Cash Flow Per Share | -0.18 | -0.37 | -0.73 | -1.40 | -1.42 | Upgrade
|
| Gross Margin | 17.42% | -243.02% | -164.58% | -142.77% | - | Upgrade
|
| Operating Margin | -25.26% | -667.78% | -424.32% | -368.13% | -744.89% | Upgrade
|
| Profit Margin | -34.05% | -1545.18% | -467.54% | -363.13% | -673.67% | Upgrade
|
| Free Cash Flow Margin | -102.61% | -321.93% | -271.87% | -355.68% | -879.03% | Upgrade
|
| EBITDA | -1.7 | -11.18 | -12.56 | -13.22 | -12.99 | Upgrade
|
| EBITDA Margin | -24.27% | - | - | -294.35% | - | Upgrade
|
| D&A For EBITDA | 0.07 | 3.72 | 3.38 | 3.31 | 1.09 | Upgrade
|
| EBIT | -1.77 | -14.9 | -15.95 | -16.53 | -14.08 | Upgrade
|
| EBIT Margin | -25.26% | - | - | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.